Challenging Occam's Razor: Dual Molecular Diagnoses Explain Entangled Clinical Pictures

Genes (Basel). 2022 Nov 3;13(11):2023. doi: 10.3390/genes13112023.

Abstract

Dual molecular diagnoses are defined as the presence of pathogenic variants at two distinct and independently segregating loci that cause two different Mendelian conditions. In this study, we report the identification of double genetic disorders in a series of patients with complex clinical features. In the last 24 months, 342 syndromic patients have been recruited and clinically characterised. Whole Exome Sequencing analysis has been performed on the proband and on both parents and identified seven patients affected by a dual molecular diagnosis. Upon a detailed evaluation of both their clinical and molecular features, subjects are able to be divided into two groups: (A) five patients who present distinct phenotypes, due to each of the two different underlying genetic diseases; (B) two patients with overlapping clinical features that may be underpinned by both the identified genetic variations. Notably, only in one case a multilocus genomic variation was already suspected during the clinical evaluation. Overall, our findings highlight how dual molecular diagnoses represent a challenging model of complex inheritance that should always be considered whenever a patient shows atypical clinical features. Indeed, an accurate genetic characterisation is of the utmost importance to provide patients with a personalised and safe clinical management.

Keywords: dual molecular diagnosis; multilocus genomic variation; whole exome sequencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Family
  • Genomics*
  • Multifactorial Inheritance*
  • Phenotype

Grants and funding

This research was supported by D70-RESRICGIROTTO, BENEFICENTIA Stiftung and Ricerca Corrente L3_14\22 to G.G. and by the Italian Ministry of Health, through the contribution given to the Institute for Maternal and Child Health I.R.C.C.S. “Burlo Garofolo”-Trieste, Italy (RCR-2020-23670068_001).